Cargando…
Detemir plus aspart and glulisine induced lipoatrophy: 2015 literature review and report of a new case
BACKGROUND: In the first and only literature review, conducted in 2009, of human insulin analog- induced lipoatrophy, there were 12 published cases, including 1 with aspart, 1 with detemir, 1 with NovoMix 30 and none with detemir plus aspart. It is perceived that insulin analog induced-lipoatrophy i...
Autores principales: | Saberi, Sima, Esfandiari, Nazanene H., MacEachern, Mark P., Tan, Meng H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471683/ https://www.ncbi.nlm.nih.gov/pubmed/28702229 http://dx.doi.org/10.1186/s40842-015-0013-5 |
Ejemplares similares
-
The Alteration of Aspart Insulin Pharmacodynamics When Mixed With Detemir Insulin
por: Cengiz, Eda, et al.
Publicado: (2012) -
Insulin glulisine in the management of diabetes
por: Yamada, Satoru
Publicado: (2009) -
Immunologic Tolerance to the Insulin Analogue Glulisine
por: Ozaki, Nobuaki, et al.
Publicado: (2010) -
Diabetic Ketosis Caused by the Insulin Analog Aspart–Induced Anti-Insulin Antibody: Successful Treatment With the Newest Insulin Analog Glulisine
por: Yanai, Hidekatsu, et al.
Publicado: (2011) -
Mixing Insulin Aspart With Detemir Does Not Affect Glucose Excursion in Children With Type 1 Diabetes
por: Nguyen, Thanh M., et al.
Publicado: (2010)